Akso Health (AHG) EBITDA Margin (2017 - 2019)
Akso Health's (AHG) quarterly EBITDA Margin came in at 20420.77% in Q3 2019, down 9458604.0% YoY from N/an in Q3 2018, and down 43217.21% on a QoQ basis from 47.14% in Q1 2019.
Akso Health (AHG) EBITDA Margin (2017 - 2019) Analysis & Trends
Akso Health (AHG) has 3 years of EBITDA Margin data on file, last reported at 20420.77% in Q3 2019.
- Quarterly EBITDA Margin fell 9458604.0% year-over-year to 20420.77% in Q3 2019, while the trailing twelve-month figure through Sep 2019 was 168.81% (down 25418.0% YoY) and the FY2026 annual result came in at 149.66%, up 97571.0% from the prior year.
- EBITDA Margin retreated to 20420.77% in Q3 2019, from 47.14% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 74165.27% in Q3 2018 to a low of 20420.77% in Q3 2019.
- A 3-year average of 14033.4% and a median of 6616.54% in 2018 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2018 — EBITDA Margin surged 6472348 bps — and 2019, when it slumped 9458604 bps.
- Tracing AHG's EBITDA Margin over 3 years: stood at 9314.63% in 2017, then sank by 220 bps to 11163.44% in 2018, then slumped by 83 bps to 20420.77% in 2019.
- The last three EBITDA Margin figures came in at 20420.77% (Q3 2019), 47.14% (Q1 2019), and 11163.44% (Q4 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.37 Bn | 97.20 Bn | 3.69 Bn | 1.25% |
| 2 | Cencora | 61.76 Bn | 58.95 Bn | 3.61 Bn | 1.50% |
| 3 | Cardinal Health | 54.30 Bn | 49.44 Bn | 2.56 Bn | 1.14% |
| 4 | Henry Schein | 10.06 Bn | 9.90 Bn | 1.10 Bn | 4.95% |
| 5 | Akso Health | 820.26 Mn | 820.04 Mn | - | - |
| 6 | Edap Tms | 154.99 Mn | 133.45 Mn | 7.34 Mn | -60.84% |
| 7 | Accendra Health | 94.33 Mn | 86.68 Mn | 263.41 Mn | -5.73% |
| 8 | 111 | 30.87 Mn | 109.39 Mn | 18.18 Mn | -0.84% |
| 9 | Cosmos Health | 13.33 Mn | 10.89 Mn | 1.51 Mn | -14.82% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | -6.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -20,420.77% |
| Mar 31, 2019 | -47.14% |
| Dec 31, 2018 | -11,163.44% |
| Sep 30, 2018 | 74,165.27% |
| Jun 30, 2018 | 6,616.54% |
| Mar 31, 2018 | 16.64% |
| Dec 31, 2017 | 9,314.63% |
| Sep 30, 2017 | 9,441.79% |
| Jun 30, 2017 | 58,377.07% |